The global Surgical Suture market gathered revenue around USD 4.0 Billion in 2020 and market is set to grow USD 5.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.8% during the prediction period 2021 to 2027. The market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures performed globally. The favorable reimbursement scenario for a number of surgical procedures and the launch of advanced sutures are further contributing to the growth of this market. However, the presence of alternative wound care management products and the growing preference for minimally invasive surgeries are some of the factors expected to limit the growth of this market to a certain extent.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Surgical Suture market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Surgical Suture market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Surgical Suture market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Restrains : Presence of alternative wound care management products
Topical skin adhesives, hemostatic and sealing agents (such as fibrin sealants, surgical sealants, gelatin-based sealants, human fibrinogen, and thrombin fleeces), and wound closure devices (such as stapling devices, ligating clips, and wound closure strips) are some alternatives to surgical sutures.
These alternative products are associated with certain advantages. For instance, stapling is quicker than suturing. Furthermore, the area requiring suturing is an important factor for determining the selection of material. In the case of head injuries, a stapler can work quickly, saving time and blood loss, thus making it a preferred choice over sutures. Similarly, small incisions and wounds (less than 10 cm) can be closed by tissue adhesives in a relatively painless procedure for pediatric patients without the need for removal, as in the case of sutures. Wound closure strips and tapes can also be used to close smaller lacerations. These products provide better closure and prognosis in the case of elderly patients, especially those with frail skin. Due to their efficiency and benefits over surgical sutures, the availability of alternatives is a key restraint for this market.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Surgical Suture Market are:
The surgical sutures market are Ethicon, Inc. (US), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Smith & Nephew plc (UK), Boston Scientific Corporation (US), Peters Surgical (France), DemeTECH Corporation (US), Internacional Farmacéutica (Mexico), Sutures India (India), EndoEvolution, LLC (US), Apollo Endosurgery, Inc. (US), Surgical Specialties Corporation (US), and Mellon Medical B.V. (Netherlands).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
The study categorizes the surgical suture market based on By Type of Product, Mode of Delivery, and Animal Type at the regional and global level.
Surgical Sutures Market, by Product
Surgical Sutures Market, by Application
Surgical Sutures Market, by End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Surgical Suture Market, By Product
7.1. Surgical Suture Market, by Product, 2021-2027
7.1.1. Suture Threads
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Non-absorbable Sutures
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Absorbable Sutures
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Surgical Suture Market, By Application
8.1. Surgical Suture Market, By Application, 2021-2027
8.1.1. Cardiovascular Surgery
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. General Surgery
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Gynecological Surgery
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Ophthalmic Surgery
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Cosmetic & Plastic Surgery
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Other Applications
8.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Surgical Suture Market, By End User
9.1. Surgical Suture Market, By End User, 2021-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. End User 3
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Hospitals
9.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Surgical Suture Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.2. Market Revenue and Forecast, By Application (2016-2027)
10.1.3. Market Revenue and Forecast, By End User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, By End User (2016-2027)
Chapter 11. Company Profiles
11.1. Ethicon, Inc. (US)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Medtronic plc (Ireland)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. B. Braun Melsungen AG (Germany)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Smith & Nephew plc (UK)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Boston Scientific Corporation (US)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Peters Surgical (France)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. DemeTECH Corporation (US)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Internacional Farmacéutica (Mexico)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Sutures India (India)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. EndoEvolution, LLC (US)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Apollo Endosurgery, Inc. (US)
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Surgical Specialties Corporation (US)
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Mellon Medical B.V. (Netherlands)
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms